POMALYST® (pomalidomide) is a thalidomide analogue indicated, in combination with dexamethasone, for adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

A single source for
access support.
Celgene Patient Support® provides:
- A single Specialist assigned to help patients in your geographic area
- Assistance with understanding patient insurance coverage for POMALYST
- Information about financial assistance for POMALYST
Financial assistance.
Depending on your patient’s insurance situation, there are programs and organizations that may help pay for POMALYST.
Celgene commercial co-pay program
For eligible patients with commercial or private insurance (including healthcare exchanges),* co-pay responsibility for POMALYST is reduced to $25 (subject to annual benefit limit).
Celgene Patient Assistance Program (PAP)
For qualified patients who are uninsured or underinsured, POMALYST may be available at no cost.†
Independent third-party organizations
For patients who are unable to afford their medication (including patients with Medicare, Medicaid, or other government-sponsored insurance),‡ independent third-party organizations may be able to help.
*Eligibility requirements and restrictions apply. Please see full Terms and Conditions on the Celgene Patient Support® website.
†Patients must meet specified financial and insurance eligibility requirements to qualify for assistance. Please see Eligibility Requirements on the Celgene Patient Support® website.
‡Financial and medical eligibility requirements may vary by organization.
Insurance-related assistance.
Our Specialists are available to assist with each of the following steps in the insurance approval process for POMALYST.§
- Benefits Investigation
- Prior authorization assistanceII
- Appeals assistanceII
§Celgene cannot provide insurance advice or make insurance decisions.
IICelgene provides a facilitation service and will not provide any medical input into a prior authorization or an appeal.
Enrolling in Celgene Patient Support.
There are three simple ways to enroll in Celgene Patient Support®.
Enroll Online
Enroll online at www.celgenepatientsupport.com.
Call 1-800-931-8691
Call us at 1-800-931-8691, Monday-Friday, 8 AM – 8 PM ET
(translation services available).
Email or fax the enrollment form.
Email us at patientsupport@celgene.com or fax 1-800-822-2496.